0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Imipenem Cilastatin Sodium API Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-9W16742
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Imipenem Cilastatin Sodium API Market Research Report 2024
BUY CHAPTERS

Global Imipenem Cilastatin Sodium API Market Research Report 2025

Code: QYRE-Auto-9W16742
Report
June 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Imipenem Cilastatin Sodium API Market

The global market for Imipenem Cilastatin Sodium API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Imipenem and cilastatin injection is used to treat certain serious infections that are caused by bacteria, including endocarditis (infection of the heart lining and valves) and respiratory tract (including pneumonia), urinary tract, abdominal (stomach area), gynecological, blood, skin, bone, and joint infections. Imipenem is in a class of medications called carbapenem antibiotics. It works by killing bacteria. Cilastatin is in a class of medications called dehydropeptidase inhibitors. It works by helping imipenem stay active in your body for a longer period of time.
North American market for Imipenem Cilastatin Sodium API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Imipenem Cilastatin Sodium API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Imipenem Cilastatin Sodium API include Shandong New Era Pharmaceutical, Shenzhen Haibin Pharmaceutical, Sinopharm Guorui Pharmaceutical, Taiwan Biotech Co., Ltd., Merck, Sun Pharmaceutical Industries Ltd., JW Pharmaceutical, Zhengde Pharmaceutical, Hospira Inc., WG Critical Care, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Imipenem Cilastatin Sodium API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imipenem Cilastatin Sodium API.
The Imipenem Cilastatin Sodium API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Imipenem Cilastatin Sodium API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imipenem Cilastatin Sodium API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Imipenem Cilastatin Sodium API Market Report

Report Metric Details
Report Name Imipenem Cilastatin Sodium API Market
by Type
  • ≥99%
  • ≥98%
by Application
  • Pharmaceutical
  • Research
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shandong New Era Pharmaceutical, Shenzhen Haibin Pharmaceutical, Sinopharm Guorui Pharmaceutical, Taiwan Biotech Co., Ltd., Merck, Sun Pharmaceutical Industries Ltd., JW Pharmaceutical, Zhengde Pharmaceutical, Hospira Inc., WG Critical Care, Hanhui Pharmaceutical, Zhuhai United Laboratories, ACS Dobfar
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Imipenem Cilastatin Sodium API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Imipenem Cilastatin Sodium API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Imipenem Cilastatin Sodium API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Imipenem Cilastatin Sodium API Market report?

Ans: The main players in the Imipenem Cilastatin Sodium API Market are Shandong New Era Pharmaceutical, Shenzhen Haibin Pharmaceutical, Sinopharm Guorui Pharmaceutical, Taiwan Biotech Co., Ltd., Merck, Sun Pharmaceutical Industries Ltd., JW Pharmaceutical, Zhengde Pharmaceutical, Hospira Inc., WG Critical Care, Hanhui Pharmaceutical, Zhuhai United Laboratories, ACS Dobfar

What are the Application segmentation covered in the Imipenem Cilastatin Sodium API Market report?

Ans: The Applications covered in the Imipenem Cilastatin Sodium API Market report are Pharmaceutical, Research

What are the Type segmentation covered in the Imipenem Cilastatin Sodium API Market report?

Ans: The Types covered in the Imipenem Cilastatin Sodium API Market report are ≥99%, ≥98%

1 Imipenem Cilastatin Sodium API Market Overview
1.1 Product Definition
1.2 Imipenem Cilastatin Sodium API by Type
1.2.1 Global Imipenem Cilastatin Sodium API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 ≥99%
1.2.3 ≥98%
1.3 Imipenem Cilastatin Sodium API by Application
1.3.1 Global Imipenem Cilastatin Sodium API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Research
1.4 Global Market Growth Prospects
1.4.1 Global Imipenem Cilastatin Sodium API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Imipenem Cilastatin Sodium API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Imipenem Cilastatin Sodium API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Imipenem Cilastatin Sodium API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Imipenem Cilastatin Sodium API Production Market Share by Manufacturers (2020-2025)
2.2 Global Imipenem Cilastatin Sodium API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Imipenem Cilastatin Sodium API, Industry Ranking, 2023 VS 2024
2.4 Global Imipenem Cilastatin Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Imipenem Cilastatin Sodium API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Imipenem Cilastatin Sodium API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Imipenem Cilastatin Sodium API, Product Offered and Application
2.8 Global Key Manufacturers of Imipenem Cilastatin Sodium API, Date of Enter into This Industry
2.9 Imipenem Cilastatin Sodium API Market Competitive Situation and Trends
2.9.1 Imipenem Cilastatin Sodium API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Imipenem Cilastatin Sodium API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Imipenem Cilastatin Sodium API Production by Region
3.1 Global Imipenem Cilastatin Sodium API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Imipenem Cilastatin Sodium API Production Value by Region (2020-2031)
3.2.1 Global Imipenem Cilastatin Sodium API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Imipenem Cilastatin Sodium API by Region (2026-2031)
3.3 Global Imipenem Cilastatin Sodium API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Imipenem Cilastatin Sodium API Production Volume by Region (2020-2031)
3.4.1 Global Imipenem Cilastatin Sodium API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Imipenem Cilastatin Sodium API by Region (2026-2031)
3.5 Global Imipenem Cilastatin Sodium API Market Price Analysis by Region (2020-2025)
3.6 Global Imipenem Cilastatin Sodium API Production and Value, Year-over-Year Growth
3.6.1 North America Imipenem Cilastatin Sodium API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Imipenem Cilastatin Sodium API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Imipenem Cilastatin Sodium API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Imipenem Cilastatin Sodium API Production Value Estimates and Forecasts (2020-2031)
4 Imipenem Cilastatin Sodium API Consumption by Region
4.1 Global Imipenem Cilastatin Sodium API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Imipenem Cilastatin Sodium API Consumption by Region (2020-2031)
4.2.1 Global Imipenem Cilastatin Sodium API Consumption by Region (2020-2025)
4.2.2 Global Imipenem Cilastatin Sodium API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Imipenem Cilastatin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Imipenem Cilastatin Sodium API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Imipenem Cilastatin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Imipenem Cilastatin Sodium API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Imipenem Cilastatin Sodium API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Imipenem Cilastatin Sodium API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Imipenem Cilastatin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Imipenem Cilastatin Sodium API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Imipenem Cilastatin Sodium API Production by Type (2020-2031)
5.1.1 Global Imipenem Cilastatin Sodium API Production by Type (2020-2025)
5.1.2 Global Imipenem Cilastatin Sodium API Production by Type (2026-2031)
5.1.3 Global Imipenem Cilastatin Sodium API Production Market Share by Type (2020-2031)
5.2 Global Imipenem Cilastatin Sodium API Production Value by Type (2020-2031)
5.2.1 Global Imipenem Cilastatin Sodium API Production Value by Type (2020-2025)
5.2.2 Global Imipenem Cilastatin Sodium API Production Value by Type (2026-2031)
5.2.3 Global Imipenem Cilastatin Sodium API Production Value Market Share by Type (2020-2031)
5.3 Global Imipenem Cilastatin Sodium API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Imipenem Cilastatin Sodium API Production by Application (2020-2031)
6.1.1 Global Imipenem Cilastatin Sodium API Production by Application (2020-2025)
6.1.2 Global Imipenem Cilastatin Sodium API Production by Application (2026-2031)
6.1.3 Global Imipenem Cilastatin Sodium API Production Market Share by Application (2020-2031)
6.2 Global Imipenem Cilastatin Sodium API Production Value by Application (2020-2031)
6.2.1 Global Imipenem Cilastatin Sodium API Production Value by Application (2020-2025)
6.2.2 Global Imipenem Cilastatin Sodium API Production Value by Application (2026-2031)
6.2.3 Global Imipenem Cilastatin Sodium API Production Value Market Share by Application (2020-2031)
6.3 Global Imipenem Cilastatin Sodium API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Shandong New Era Pharmaceutical
7.1.1 Shandong New Era Pharmaceutical Imipenem Cilastatin Sodium API Company Information
7.1.2 Shandong New Era Pharmaceutical Imipenem Cilastatin Sodium API Product Portfolio
7.1.3 Shandong New Era Pharmaceutical Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Shandong New Era Pharmaceutical Main Business and Markets Served
7.1.5 Shandong New Era Pharmaceutical Recent Developments/Updates
7.2 Shenzhen Haibin Pharmaceutical
7.2.1 Shenzhen Haibin Pharmaceutical Imipenem Cilastatin Sodium API Company Information
7.2.2 Shenzhen Haibin Pharmaceutical Imipenem Cilastatin Sodium API Product Portfolio
7.2.3 Shenzhen Haibin Pharmaceutical Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Shenzhen Haibin Pharmaceutical Main Business and Markets Served
7.2.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
7.3 Sinopharm Guorui Pharmaceutical
7.3.1 Sinopharm Guorui Pharmaceutical Imipenem Cilastatin Sodium API Company Information
7.3.2 Sinopharm Guorui Pharmaceutical Imipenem Cilastatin Sodium API Product Portfolio
7.3.3 Sinopharm Guorui Pharmaceutical Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Sinopharm Guorui Pharmaceutical Main Business and Markets Served
7.3.5 Sinopharm Guorui Pharmaceutical Recent Developments/Updates
7.4 Taiwan Biotech Co., Ltd.
7.4.1 Taiwan Biotech Co., Ltd. Imipenem Cilastatin Sodium API Company Information
7.4.2 Taiwan Biotech Co., Ltd. Imipenem Cilastatin Sodium API Product Portfolio
7.4.3 Taiwan Biotech Co., Ltd. Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Taiwan Biotech Co., Ltd. Main Business and Markets Served
7.4.5 Taiwan Biotech Co., Ltd. Recent Developments/Updates
7.5 Merck
7.5.1 Merck Imipenem Cilastatin Sodium API Company Information
7.5.2 Merck Imipenem Cilastatin Sodium API Product Portfolio
7.5.3 Merck Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Merck Main Business and Markets Served
7.5.5 Merck Recent Developments/Updates
7.6 Sun Pharmaceutical Industries Ltd.
7.6.1 Sun Pharmaceutical Industries Ltd. Imipenem Cilastatin Sodium API Company Information
7.6.2 Sun Pharmaceutical Industries Ltd. Imipenem Cilastatin Sodium API Product Portfolio
7.6.3 Sun Pharmaceutical Industries Ltd. Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
7.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.7 JW Pharmaceutical
7.7.1 JW Pharmaceutical Imipenem Cilastatin Sodium API Company Information
7.7.2 JW Pharmaceutical Imipenem Cilastatin Sodium API Product Portfolio
7.7.3 JW Pharmaceutical Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 JW Pharmaceutical Main Business and Markets Served
7.7.5 JW Pharmaceutical Recent Developments/Updates
7.8 Zhengde Pharmaceutical
7.8.1 Zhengde Pharmaceutical Imipenem Cilastatin Sodium API Company Information
7.8.2 Zhengde Pharmaceutical Imipenem Cilastatin Sodium API Product Portfolio
7.8.3 Zhengde Pharmaceutical Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Zhengde Pharmaceutical Main Business and Markets Served
7.8.5 Zhengde Pharmaceutical Recent Developments/Updates
7.9 Hospira Inc.
7.9.1 Hospira Inc. Imipenem Cilastatin Sodium API Company Information
7.9.2 Hospira Inc. Imipenem Cilastatin Sodium API Product Portfolio
7.9.3 Hospira Inc. Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Hospira Inc. Main Business and Markets Served
7.9.5 Hospira Inc. Recent Developments/Updates
7.10 WG Critical Care
7.10.1 WG Critical Care Imipenem Cilastatin Sodium API Company Information
7.10.2 WG Critical Care Imipenem Cilastatin Sodium API Product Portfolio
7.10.3 WG Critical Care Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 WG Critical Care Main Business and Markets Served
7.10.5 WG Critical Care Recent Developments/Updates
7.11 Hanhui Pharmaceutical
7.11.1 Hanhui Pharmaceutical Imipenem Cilastatin Sodium API Company Information
7.11.2 Hanhui Pharmaceutical Imipenem Cilastatin Sodium API Product Portfolio
7.11.3 Hanhui Pharmaceutical Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Hanhui Pharmaceutical Main Business and Markets Served
7.11.5 Hanhui Pharmaceutical Recent Developments/Updates
7.12 Zhuhai United Laboratories
7.12.1 Zhuhai United Laboratories Imipenem Cilastatin Sodium API Company Information
7.12.2 Zhuhai United Laboratories Imipenem Cilastatin Sodium API Product Portfolio
7.12.3 Zhuhai United Laboratories Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Zhuhai United Laboratories Main Business and Markets Served
7.12.5 Zhuhai United Laboratories Recent Developments/Updates
7.13 ACS Dobfar
7.13.1 ACS Dobfar Imipenem Cilastatin Sodium API Company Information
7.13.2 ACS Dobfar Imipenem Cilastatin Sodium API Product Portfolio
7.13.3 ACS Dobfar Imipenem Cilastatin Sodium API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 ACS Dobfar Main Business and Markets Served
7.13.5 ACS Dobfar Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Imipenem Cilastatin Sodium API Industry Chain Analysis
8.2 Imipenem Cilastatin Sodium API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Imipenem Cilastatin Sodium API Production Mode & Process Analysis
8.4 Imipenem Cilastatin Sodium API Sales and Marketing
8.4.1 Imipenem Cilastatin Sodium API Sales Channels
8.4.2 Imipenem Cilastatin Sodium API Distributors
8.5 Imipenem Cilastatin Sodium API Customer Analysis
9 Imipenem Cilastatin Sodium API Market Dynamics
9.1 Imipenem Cilastatin Sodium API Industry Trends
9.2 Imipenem Cilastatin Sodium API Market Drivers
9.3 Imipenem Cilastatin Sodium API Market Challenges
9.4 Imipenem Cilastatin Sodium API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Imipenem Cilastatin Sodium API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Imipenem Cilastatin Sodium API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Imipenem Cilastatin Sodium API Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Imipenem Cilastatin Sodium API Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Imipenem Cilastatin Sodium API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Imipenem Cilastatin Sodium API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Imipenem Cilastatin Sodium API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Imipenem Cilastatin Sodium API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Imipenem Cilastatin Sodium API as of 2024)
 Table 10. Global Market Imipenem Cilastatin Sodium API Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Imipenem Cilastatin Sodium API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Imipenem Cilastatin Sodium API, Product Offered and Application
 Table 13. Global Key Manufacturers of Imipenem Cilastatin Sodium API, Date of Enter into This Industry
 Table 14. Global Imipenem Cilastatin Sodium API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Imipenem Cilastatin Sodium API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Imipenem Cilastatin Sodium API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Imipenem Cilastatin Sodium API Production Value Market Share by Region (2020-2025)
 Table 19. Global Imipenem Cilastatin Sodium API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Imipenem Cilastatin Sodium API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Imipenem Cilastatin Sodium API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Imipenem Cilastatin Sodium API Production (Tons) by Region (2020-2025)
 Table 23. Global Imipenem Cilastatin Sodium API Production Market Share by Region (2020-2025)
 Table 24. Global Imipenem Cilastatin Sodium API Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Imipenem Cilastatin Sodium API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Imipenem Cilastatin Sodium API Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Imipenem Cilastatin Sodium API Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Imipenem Cilastatin Sodium API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Imipenem Cilastatin Sodium API Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Imipenem Cilastatin Sodium API Consumption Market Share by Region (2020-2025)
 Table 31. Global Imipenem Cilastatin Sodium API Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Imipenem Cilastatin Sodium API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Imipenem Cilastatin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Imipenem Cilastatin Sodium API Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Imipenem Cilastatin Sodium API Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Imipenem Cilastatin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Imipenem Cilastatin Sodium API Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Imipenem Cilastatin Sodium API Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Imipenem Cilastatin Sodium API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Imipenem Cilastatin Sodium API Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Imipenem Cilastatin Sodium API Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Imipenem Cilastatin Sodium API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Imipenem Cilastatin Sodium API Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Imipenem Cilastatin Sodium API Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Imipenem Cilastatin Sodium API Production (Tons) by Type (2020-2025)
 Table 46. Global Imipenem Cilastatin Sodium API Production (Tons) by Type (2026-2031)
 Table 47. Global Imipenem Cilastatin Sodium API Production Market Share by Type (2020-2025)
 Table 48. Global Imipenem Cilastatin Sodium API Production Market Share by Type (2026-2031)
 Table 49. Global Imipenem Cilastatin Sodium API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Imipenem Cilastatin Sodium API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Imipenem Cilastatin Sodium API Production Value Market Share by Type (2020-2025)
 Table 52. Global Imipenem Cilastatin Sodium API Production Value Market Share by Type (2026-2031)
 Table 53. Global Imipenem Cilastatin Sodium API Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Imipenem Cilastatin Sodium API Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Imipenem Cilastatin Sodium API Production (Tons) by Application (2020-2025)
 Table 56. Global Imipenem Cilastatin Sodium API Production (Tons) by Application (2026-2031)
 Table 57. Global Imipenem Cilastatin Sodium API Production Market Share by Application (2020-2025)
 Table 58. Global Imipenem Cilastatin Sodium API Production Market Share by Application (2026-2031)
 Table 59. Global Imipenem Cilastatin Sodium API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Imipenem Cilastatin Sodium API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Imipenem Cilastatin Sodium API Production Value Market Share by Application (2020-2025)
 Table 62. Global Imipenem Cilastatin Sodium API Production Value Market Share by Application (2026-2031)
 Table 63. Global Imipenem Cilastatin Sodium API Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Imipenem Cilastatin Sodium API Price (US$/Ton) by Application (2026-2031)
 Table 65. Shandong New Era Pharmaceutical Imipenem Cilastatin Sodium API Company Information
 Table 66. Shandong New Era Pharmaceutical Imipenem Cilastatin Sodium API Specification and Application
 Table 67. Shandong New Era Pharmaceutical Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. Shandong New Era Pharmaceutical Main Business and Markets Served
 Table 69. Shandong New Era Pharmaceutical Recent Developments/Updates
 Table 70. Shenzhen Haibin Pharmaceutical Imipenem Cilastatin Sodium API Company Information
 Table 71. Shenzhen Haibin Pharmaceutical Imipenem Cilastatin Sodium API Specification and Application
 Table 72. Shenzhen Haibin Pharmaceutical Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Shenzhen Haibin Pharmaceutical Main Business and Markets Served
 Table 74. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
 Table 75. Sinopharm Guorui Pharmaceutical Imipenem Cilastatin Sodium API Company Information
 Table 76. Sinopharm Guorui Pharmaceutical Imipenem Cilastatin Sodium API Specification and Application
 Table 77. Sinopharm Guorui Pharmaceutical Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Sinopharm Guorui Pharmaceutical Main Business and Markets Served
 Table 79. Sinopharm Guorui Pharmaceutical Recent Developments/Updates
 Table 80. Taiwan Biotech Co., Ltd. Imipenem Cilastatin Sodium API Company Information
 Table 81. Taiwan Biotech Co., Ltd. Imipenem Cilastatin Sodium API Specification and Application
 Table 82. Taiwan Biotech Co., Ltd. Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Taiwan Biotech Co., Ltd. Main Business and Markets Served
 Table 84. Taiwan Biotech Co., Ltd. Recent Developments/Updates
 Table 85. Merck Imipenem Cilastatin Sodium API Company Information
 Table 86. Merck Imipenem Cilastatin Sodium API Specification and Application
 Table 87. Merck Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Merck Main Business and Markets Served
 Table 89. Merck Recent Developments/Updates
 Table 90. Sun Pharmaceutical Industries Ltd. Imipenem Cilastatin Sodium API Company Information
 Table 91. Sun Pharmaceutical Industries Ltd. Imipenem Cilastatin Sodium API Specification and Application
 Table 92. Sun Pharmaceutical Industries Ltd. Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
 Table 94. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 95. JW Pharmaceutical Imipenem Cilastatin Sodium API Company Information
 Table 96. JW Pharmaceutical Imipenem Cilastatin Sodium API Specification and Application
 Table 97. JW Pharmaceutical Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. JW Pharmaceutical Main Business and Markets Served
 Table 99. JW Pharmaceutical Recent Developments/Updates
 Table 100. Zhengde Pharmaceutical Imipenem Cilastatin Sodium API Company Information
 Table 101. Zhengde Pharmaceutical Imipenem Cilastatin Sodium API Specification and Application
 Table 102. Zhengde Pharmaceutical Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Zhengde Pharmaceutical Main Business and Markets Served
 Table 104. Zhengde Pharmaceutical Recent Developments/Updates
 Table 105. Hospira Inc. Imipenem Cilastatin Sodium API Company Information
 Table 106. Hospira Inc. Imipenem Cilastatin Sodium API Specification and Application
 Table 107. Hospira Inc. Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Hospira Inc. Main Business and Markets Served
 Table 109. Hospira Inc. Recent Developments/Updates
 Table 110. WG Critical Care Imipenem Cilastatin Sodium API Company Information
 Table 111. WG Critical Care Imipenem Cilastatin Sodium API Specification and Application
 Table 112. WG Critical Care Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. WG Critical Care Main Business and Markets Served
 Table 114. WG Critical Care Recent Developments/Updates
 Table 115. Hanhui Pharmaceutical Imipenem Cilastatin Sodium API Company Information
 Table 116. Hanhui Pharmaceutical Imipenem Cilastatin Sodium API Specification and Application
 Table 117. Hanhui Pharmaceutical Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Hanhui Pharmaceutical Main Business and Markets Served
 Table 119. Hanhui Pharmaceutical Recent Developments/Updates
 Table 120. Zhuhai United Laboratories Imipenem Cilastatin Sodium API Company Information
 Table 121. Zhuhai United Laboratories Imipenem Cilastatin Sodium API Specification and Application
 Table 122. Zhuhai United Laboratories Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Zhuhai United Laboratories Main Business and Markets Served
 Table 124. Zhuhai United Laboratories Recent Developments/Updates
 Table 125. ACS Dobfar Imipenem Cilastatin Sodium API Company Information
 Table 126. ACS Dobfar Imipenem Cilastatin Sodium API Specification and Application
 Table 127. ACS Dobfar Imipenem Cilastatin Sodium API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. ACS Dobfar Main Business and Markets Served
 Table 129. ACS Dobfar Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Imipenem Cilastatin Sodium API Distributors List
 Table 133. Imipenem Cilastatin Sodium API Customers List
 Table 134. Imipenem Cilastatin Sodium API Market Trends
 Table 135. Imipenem Cilastatin Sodium API Market Drivers
 Table 136. Imipenem Cilastatin Sodium API Market Challenges
 Table 137. Imipenem Cilastatin Sodium API Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Imipenem Cilastatin Sodium API
 Figure 2. Global Imipenem Cilastatin Sodium API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Imipenem Cilastatin Sodium API Market Share by Type: 2024 VS 2031
 Figure 4. ≥99% Product Picture
 Figure 5. ≥98% Product Picture
 Figure 6. Global Imipenem Cilastatin Sodium API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Imipenem Cilastatin Sodium API Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical
 Figure 9. Research
 Figure 10. Global Imipenem Cilastatin Sodium API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Imipenem Cilastatin Sodium API Production Value (US$ Million) & (2020-2031)
 Figure 12. Global Imipenem Cilastatin Sodium API Production Capacity (Tons) & (2020-2031)
 Figure 13. Global Imipenem Cilastatin Sodium API Production (Tons) & (2020-2031)
 Figure 14. Global Imipenem Cilastatin Sodium API Average Price (US$/Ton) & (2020-2031)
 Figure 15. Imipenem Cilastatin Sodium API Report Years Considered
 Figure 16. Imipenem Cilastatin Sodium API Production Share by Manufacturers in 2024
 Figure 17. Global Imipenem Cilastatin Sodium API Production Value Share by Manufacturers (2024)
 Figure 18. Imipenem Cilastatin Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Imipenem Cilastatin Sodium API Revenue in 2024
 Figure 20. Global Imipenem Cilastatin Sodium API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 21. Global Imipenem Cilastatin Sodium API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 22. Global Imipenem Cilastatin Sodium API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 23. Global Imipenem Cilastatin Sodium API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. North America Imipenem Cilastatin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 25. Europe Imipenem Cilastatin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. China Imipenem Cilastatin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Japan Imipenem Cilastatin Sodium API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Global Imipenem Cilastatin Sodium API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 29. Global Imipenem Cilastatin Sodium API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 30. North America Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 31. North America Imipenem Cilastatin Sodium API Consumption Market Share by Country (2020-2031)
 Figure 32. U.S. Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 33. Canada Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 34. Europe Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Europe Imipenem Cilastatin Sodium API Consumption Market Share by Country (2020-2031)
 Figure 36. Germany Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. France Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. U.K. Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Italy Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Russia Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Asia Pacific Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Asia Pacific Imipenem Cilastatin Sodium API Consumption Market Share by Region (2020-2031)
 Figure 43. China Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Japan Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. South Korea Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. China Taiwan Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. Southeast Asia Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. India Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Latin America, Middle East & Africa Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. Latin America, Middle East & Africa Imipenem Cilastatin Sodium API Consumption Market Share by Country (2020-2031)
 Figure 51. Mexico Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Brazil Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Turkey Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. GCC Countries Imipenem Cilastatin Sodium API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Global Production Market Share of Imipenem Cilastatin Sodium API by Type (2020-2031)
 Figure 56. Global Production Value Market Share of Imipenem Cilastatin Sodium API by Type (2020-2031)
 Figure 57. Global Imipenem Cilastatin Sodium API Price (US$/Ton) by Type (2020-2031)
 Figure 58. Global Production Market Share of Imipenem Cilastatin Sodium API by Application (2020-2031)
 Figure 59. Global Production Value Market Share of Imipenem Cilastatin Sodium API by Application (2020-2031)
 Figure 60. Global Imipenem Cilastatin Sodium API Price (US$/Ton) by Application (2020-2031)
 Figure 61. Imipenem Cilastatin Sodium API Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Feline Infectious Peritonitis (FIP) Antivirals Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4U20267
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Anticoccidial Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-16R16865
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Bacterial Enteric Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-3F17301
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Whooping Cough Vaccination Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-4B20221
Wed Nov 12 00:00:00 UTC 2025

Add to Cart